Biocon Limited (NSE: BIOCON) named among Science Magazine’s Best Employers in Global Biotech and Pharma for 2026, reflecting its strong culture and social re.
Syngene International Limited reports 13% sequential revenue growth in Q2 FY27, with improved operating EBITDA margin.
Fermenta Biotech Limited (FERMENTA) announced consolidated revenue of INR 126.2 crore for Q1FY27, flat QoQ and down 13% YoY.
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES) reports a 2% revenue increase and a 5% PAT decline for Q1 FY27.
Fermenta Biotech Limited (FERMENTA) lists on India’s National Stock Exchange, enhancing accessibility and participation.
Syngene International Limited (NSE: SYNGENE) appoints Siddharth Mittal as new Managing Director & CEO, effective July 1, 2026.
Shilpa Medicare Limited (NSE: SHILPAMED) announces expanded partnership with Orion Corporation for developing and supplying nivolumab biosimilar in Europe.
Ipca Laboratories (IPCALAB) partners with Bhami’s Research Laboratory for global licensing of novel subcutaneous biologics delivery technology.
Biocon Limited reports strong Q4 and full year FY26 results, showing significant growth and strategic execution.